<DOC>
	<DOC>NCT00859560</DOC>
	<brief_summary>The retrospective survey is to investigate the incidence of bone fracture in post-menopausal breast cancer patients with Arimidex 1mg, who were previously registered for the clinical experience investigation.</brief_summary>
	<brief_title>Retrospective Survey of Bone Fracture in Patients With Arimidex 1mg</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Fractures, Bone</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<criteria>Postmenopausal breast cancer patients treated with Arimidex 1mg at the time of previously conducted clinical experience investigation.</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>post-menopausal women</keyword>
	<keyword>Arimidex</keyword>
	<keyword>bone fracture</keyword>
</DOC>